5/13/2026Strategic Partnerships Redefine China's Biotech Innovation Model: CBPF

5/12/2026Virax Eyes China Expansion for T-Cell Immune Profiling Platform

5/12/2026Sihuan Pharma Completes Full H-Share Conversion of Xuanzhu Biopharm

5/12/2026BMS Strikes Up to $15.2B Hengrui Alliance to Accelerate Global Drug De...

5/12/2026CureGene Raises Over CNY 300M in Series C Led by Walvax

5/12/2026Resproly Raises New Funding to Advance Inhalation Pipeline

5/12/2026Starna Raises ~US$40M in Series B+ to Advance In Vivo CAR-T and Extrah...

5/11/2026Bundxcell Completes A+ Financing to Advance iPSC-Based Regenerative Me...

5/8/2026Viatris Tops Quarterly Estimates on Strong China Performance and Brand...

5/8/2026LTZ Thera Raises $38M to Advance Myeloid-Engager Immunotherapy Pipelin...

5/7/2026Novo Nordisk Signals Delays for Ozempic Generics in China Despite Pate...

5/7/2026GSK Expands China Biotech Push With Up to US$1 Billion siRNA Obesity D...

5/5/2026Gyre Thera Closes $300M Cullgen Deal

5/5/2026Windward Bio Raises $165M to Advance China-Origin Asthma Drug Into Pha...

5/5/2026UCB's $2.2B Candid Deal Highlights China-Origin Innovation Flowing Int...

5/1/2026Shanghai Pharma Completes Exit from Sino-US JV with $140M Stake Sale t...

5/1/2026China Pharma Trade Rises 4.22% in Q1 as Exports Shift Toward High-Valu...

4/30/2026Livzon Takes Control of Vietnam's Imexpharm in $228M Deal

4/30/2026Vivacta Bio Raises $50M+ to Advance In Vivo CAR-T Platform into Clinic...

4/30/2026Kanova Raises Hundreds of Millions in New Round

4/29/2026Samsung Bioepis Expands into China with ATLATL Partnership to Boost In...

4/29/2026AstraZeneca Secures Dual First-Line Liver Cancer Approvals in China fo...

4/29/2026BeOne Expands Multispecific Pipeline With Potential $2B+ HuaHui Immuno...

4/29/2026Aureka Bio Raises $35M to Advance AI-Driven Antibody Discovery Platfor...

4/29/2026Mabwell Lists in Hong Kong in First "A-to-H 18A" Biotech Debut

4/28/2026China Accelerates Biobank Buildout as Data Becomes Strategic Asset in ...

4/28/2026Sun Pharma's $11.75B Organon Deal Signals Major Push Into China Market

4/28/2026QL Biopharma Files Hong Kong IPO to Advance Next-Gen Metabolic Pipelin...

4/27/2026Adcoris Out-Licenses 5T4 ADC to NewCo in Global Deal with K2 Therapeut...

4/27/2026Novamab Raises ~CNY 300M Series B+ to Advance Inhaled and Oral Nanobod...

Page:1/26 Total number of articles:756: [First][<<] [1] [2] [3] [4] [5] [>>] [End]